Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Peptide Vaccine +/- Cyclophosphamide in Resected Melanoma
NCT00118274Phase 2Completed
- Start
- Mar 2005
- Primary completion
- Feb 2010
- Modality
- Peptides, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of melanoma helper peptide vaccine in melanoma. Started Mar 2005; status: completed.
02
Drugs
melanoma helper peptide vaccine
03
Conditions
melanoma
Beyond the preview
Go deeper on NCT00118274.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00118274.